Latest On-Demand Webinars

In this webinar, Dr. Catherine Houlihan, will describe an unrecognized case of viral hemorrhagic fever imported into the UK and the important lessons learned for the emergency clinicians, GPs, virologists, infection specialists and public health doctors.

In this webinar, we will highlight the impact TIMS can have on separating metabolites for acquiring MS/MS fragmentation patterns and explore how TIMS is used in a variety of experimental workflows including metabolome profiling and fluxomics experiments.

This webinar discusses an analytical approach for N-linked glycan analysis using the SLIM-based high-resolution ion mobility platform MOBIE. Results will be shown for each aspect of the overall strategy and how this platform can be an integral part for the characterization of protein therapeutics.

In this webinar, we will cover time-saving tips to help increase your PCR productivity. We will address common PCR pitfalls that can be avoided with innovations in enzymes, instruments, and plastics. We will also discuss PCR tools that are available to researchers who wish to push PCR boundaries to overcome research limitations.

Point-of-care testing is the future of diagnostic solutions. The main reason for this is point-of-care testing is robust, easy to use and provides immediate results and thus allows treatment decisions to be made more quickly. As an additional benefit, point-of-care diagnostic testing brings value to patients and healthcare systems.

We are here to help progress point-of-care diagnostics with our glycerol-free enzymes. Lyo-ready enzymes are as efficient and as high in performance as traditional formats of enzymes and this new formulation is suitable for use in microfluidics instruments.

The momentous success of mRNA vaccines has prompted the exploration of new analytical approaches for supporting the development, production and deployment of new nucleic acid therapeutics.

In this webinar you will gain a deeper understanding of how to measure oligonucleotide in a robust environment with high isotopic fidelity mass spectrometry and much more.

Mass spectrometry-based proteomics has been the technique of choice for deep and quantitative analysis of proteomes. However, until recently, the characterization of these proteomes was represented by the bulk analysis of many thousands to millions of cells. Only recently have the approaches and instrumentation afforded characterization of peptides from hundreds to even just a single cell.

Biotherapeutics such as monoclonal antibodies and other proteins are routinely analyzed by size exclusion chromatography (SEC) to detect high and low molecular weight impurities (aggregates or fragments). Predominantly, UV absorbance is used for detection. However, advanced detection technologies namely multiangle light scattering (MALS) and mass spectrometry (MS) better characterize proteins and reveal species hidden in UV chromatograms.

This webinar will explain the different detection methods and their results. Special emphasis will be placed on the higher requirements for size exclusion columns preceding advanced detection methods.

Speaking at Proteomics & Metabolomics 2022, Mohit Jain from Bruker, presented their talk on small molecule biomarkers in drug development.